URO-BCG-4 : Bladder Tumors Immunotherapy

计划入组 146 人 · 首次发布于 2005 年 9 月 21 日

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

计划入组 1 人 · 首次发布于 2017 年 4 月 10 日

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

计划入组 190 人 · 首次发布于 2006 年 10 月 6 日

BCG vaccine

BCG-005

BCG-007

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

United States

Janssen Alzheimer Immunotherapy Research & Development LLC

United States

PETER MACCALLUM CANCER INSTITUTE

Australia

BCG Immunotherapy Reprograms CNS Immunity and Alters Amyloid Dynamics in Older Adults

ImmVira Initiates Phase II Trial for Novel Oncolytic Immunotherapy in BCG-Unresponsive Bladder Cancer

TAR-200 Demonstrates High Complete Response in BCG-Unresponsive Bladder Cancer